EVENING BULLETIN 🚦 *Date:* 15-May-2025 --- 📍 *ORDER WINS / CONTRACTS / NEW PROJECTS* *KALPATARU PROJECTS*: Secures ₹2,372 crore orders in Power T\&D and Buildings & Factories segments. *REMSONS*: Bags ₹300 crore cable supply contract from Stellantis North America. *SEPC*: Receives ₹18 crore O\&M work orders from Bajaj Energy for five plants in Uttar Pradesh. *BRAHMAPUTRA INFRA JV*: Wins ₹91.5 crore EPC contract for EMRS schools in Arunachal Pradesh. *GPT INFRA*: Gets ₹32.29 crore order from Eastern Railway for concrete sleepers. *KILBURN ENGINEERING*: Secures ₹28.21 crore worth orders across multiple product lines. *SHRADDHA PRIME*: Takes on ₹420 crore Mulund redevelopment project. *MEDICO REMEDIES*: Commissions new antibiotics plant; targets ₹25 crore revenue post-approvals. *ROYAL ORCHID HOTELS*: Launches 75-key beachfront Regenta Resort in Dapoli. *TIME TECHNOPLAST*: Achieves French certification for hydrogen composite cylinders. *HIMALAYA FOOD*: Secures export order for French fries to the US; production starts this week. --- 📍 *FUNDRAISING / EQUITY / DEBT* *GENESYS*: To raise ₹110 crore via QIP at ₹632.32/share, at a 13% discount to CMP. *BIOCON*: Eyes ₹4,500 crore QIP to increase stake in Biologics, per Kiran Mazumdar-Shaw. *AIRTEL (SINGTEL PROMOTER)*: To offload ₹8,568 crore worth shares via block deal on May 16. --- 📍 *REGULATORY APPROVALS / USFDA* *MARKSANS PHARMA*: Gets UKMHRA nod for Gabapentin oral solution via UK arm. *ALEMBIC PHARMA*: Receives USFDA approval for Rivaroxaban; to launch 2.5mg in Q1FY26. *LUPIN*: Gains USFDA approval for Rivaroxaban, expanding its US portfolio. --- 📍 *COLLABORATIONS / STRATEGIC PARTNERSHIPS* *HCLTECH & MICROSOFT*: Launch AI-driven SAP migration solution. *SBI CARD & APOLLO HEALTHCO*: Unveil co-branded Apollo SBI SELECT credit card. *INFOSYS*: Expands strategic agreement with Norway’s DNB Bank for digital transformation. --- 📍 *LEADERSHIP CHANGES / CORPORATE GOVERNANCE* *INDUSIND BANK*: Under SEBI probe for alleged insider trading violations. *PERSISTENT SYSTEMS*: Under investigation via UnitedHealth for alleged Medicare fraud. --- 📍 *EARNINGS / QUARTERLY RESULTS (Q4)* *ARVIND*: Net profit jumps to ₹151 crore vs ₹99 crore YoY; margins decline to 11.05%. *CESC*: Net falls to ₹373 crore vs ₹400 crore YoY; EBITDA doubles YoY to ₹812 crore. *WELSPUN ENTERPRISES*: Profit at ₹100 crore; revenue climbs to ₹1,021 crore. *PAGE INDUSTRIES*: Net profit at ₹160 crore; EBITDA margin improves to 21.4%. *GODREJ INDUSTRIES*: Swings to ₹183 crore profit; revenue rises 26.5% YoY. *PRICOL*: Net profit drops 15.8% YoY to ₹34.94 crore; revenue surges 32.8%. *NCC*: Net up 6.1% YoY to ₹253.8 crore; margins improve to 9.07%. *JSW ENERGY*: Profit up 16.1% YoY at ₹408 crore; strong QoQ performance. *LT FOODS*: Profit up 8% YoY at ₹160.5 crore; margins remain steady. *TEGA INDUSTRIES*: Net up 13.9% YoY at ₹101.9 crore; EBITDA grows 8%. *CROMPTON GREAVES*: Profit up 10.8% YoY at ₹169.5 crore; margins reach 12.83%. *WEBSOL ENERGY*: Swings to ₹48.2 crore profit; revenue up 596% YoY. *STEEL STRIPS*: Profit at ₹60 crore vs ₹515 crore last year, which included exceptional gains. --- 📍 *CREDIT RATINGS / FINANCIAL HEALTH* *SUNDARAM MULTI PAP*: Reduces debt to ₹4 crore; aims to become net debt-free shortly. *BOROSIL RENEWABLES*: Gains from import duties on Chinese and Vietnamese solar glass. --- 📍 *CLARIFICATIONS / TAX ORDERS / REGULATORY FILINGS* *COCHIN SHIPYARD*: Denies ₹10,000 crore project with HD Hyundai; confirms ongoing strategic talks. *MTNL-BSNL*: Aim to monetize ₹1,000 crore in land assets during the current fiscal. --- 📍 *MARKET ACTIVITY / IPOs / FII STAKE CHANGES* *NAVNEET EDUCATION*: To form US subsidiary ‘Northstar Ventures’ for e-commerce ventures. *AIRTEL*: Launches world’s first real-time fraud detection system across all digital platforms. --- 📍 *OIL & GAS / ENERGY* *HOEC*: Resumes drilling at Kharsang Block after 12 years; KSG-71 well produces 250 barrels per day. --- 📍 *STAY UPDATED 🚦